No abstract

No abstract

Isolated bovine retinal and brain microvessels, exhibiting a patent lumen, were used to study the contribution of the microvasculature to the blood-brain and blood-retina barriers. The diffusion marker, sucrose, was taken up slowly by the isolated microvessels in contrast to leucine, tyrosine, and valine which were taken up at a considerably faster rate. Uptake of leucine was temperature dependent but resistant to inhibition by ouabain and sodium azide. The large neutral amino acids exhibited stereospecificity and cross-competition for uptake by the isolated microvessels. The apparent Kms for uptake for tyrosine, leucine, and valine were 111 M, 133 MM, and 500 M&M, respectively.The penetration into or removal of a substance from the central nervous system is a function of the interaction between that substance and the various brain barrier systems (1). These systems include the partitions between brain regions, various enzymatic barriers, the clearance and sink actions of the cerebrospinal fluid, choroid plexus and pial vessel transport, and partitioning at the blood-brain interface. From numerous morphological studies using dyes and electron-dense tracers, the barrier to the passage of substances from the blood into the brain has been thought to reside at the level of the intracerebral microvasculature (2). An indication that the microvascular endothelium, with its tight junctions, was the structural entity responsible for this barrier action and not the astrocytic processes adjacent to the microvessels was obtained when it was demonstrated that intraventricularly injected horseradish peroxidase appeared in the pericapillary space (3). Similarly, the impenetrability of the retinal microvasculature to dyes and electron-dense tracers (4) has been attributed to its endothelial tight junctions. In addition, both the retinal and brain microvascular endothelium have low rates of vesicle formation which further decreases the movement of molecules across this cell layer (5). Additional involvement of the cerebral microvasculature in blood-brain partitioning has been demonstrated by in situ carotid artery injection quickly followed by decapitation and determination of brain extraction of the injected test substance (6). Because of the short time interval between injection and decapitation, it has been assumed that the extraction of the test substance was an index of microvascular activity.To more directly characterize the role of the cerebral microvasculature in the partitioning of small molecules between the blood and the brain and to develop methods for the study of such phenomena in vitro, we examined isolated intracerebral bovine brain microvessels and the anatomically similar retinal microvessels for their abilities to exclude certain polar substances and to transport large neutral amino acids. Beef brains and enucleated eyes from yearling animals were obtained from a slaughterhouse, packed in ice, and taken to the laboratory within 30 min of death. MATERIALS AND METHODS MaterialsPreparation of Microvessels...

No abstract

1. Methylaplysinopsin is an indolyl-methylene derivative of creatinin which was isolated from a sponge collected on the Great Barrier Reef. 2. It is a potent inhibitor of tetrabenazine-induced responses in rats and mice and appears to act through several mechanisms, each of which enhances central serotonergic function. 3. As a reversible inhibitor of type A monoamine oxidase (MAO) methylaplysinopsin is relatively short-acting and has a Ki of 0.2 mumol/l when serotonin is the substrate used. 4. Methylaplysinopsin (10(-4) mol/l) also releases [3H]-serotonin from prelabelled synaptosomes, but has little effect on release of [3H]-noradrenaline ([3H]-NA) from a similar preparation. 5. In blocking uptake of [3H]-serotonin into cerebral cortical synaptosomes, methylaplysinopsin has a potency similar to that of imipramine (Ki = 2 X 10(-7) mol/l cf. 5 X 10(-7) mol/l), but it is considerably less potent in blocking [3H]-NA uptake. 6. Methylaplysinopsin is a weak displacer of [3H]-serotonin specific binding (IC50 = 160 mumol/l for hippocampal membrane preparations and 66 mumol/l for crude homogenates of rat brain). 7. Thus, methylaplysinopsin has effects on various aspects of serotonergic function. Whilst some of these effects are weak, they appear relatively selective for this neurochemical system.

No abstract

The effects of gestational age on the pharmacokinetics of cefotaxime and its desacetyl metabolite during the first days of life was investigated in a group of four full-term infants and 12 preterm infants of less than 35 weeks gestation. Half of the preterm infants had received betamethasone, a drug known to facilitate hepatic microsomal drug metabolism, whilst the others had not. No significant differences in the pharmacokinetics of cefotaxime were observed between the various groups, with elimination half-life (T 1/2 beta) of cefotaxime ranging from 4.04 +/- 1.52 to 4.56 +/- 1.31 h. The desacetyl metabolite of cefotaxime was present in all post-dose serum samples, irrespective of the gestational age of the baby. Its formation was apparently unaffected by prior exposure to betamethasone. The elimination half-life of cefotaxime is significantly longer in newborn infants than in older children or adults, this increase probably results from decreased renal excretion of the drug, rather than from immaturity in its metabolism. A dose of 50 mg/kg of cefotaxime given every 12 h is appropriate for infants of less than seven days old.

No abstract